Janney Montgomery Scott’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$51K	Buy	+10,100	New	+$51K	﹤0.01%	2677
2024 Q2	–	Sell	-31,095	Closed	-$310K	–	2787
2024 Q1	$310K	Buy	+31,095	New	+$310K	﹤0.01%	2319
2023 Q4	–	Sell	-15,270	Closed	-$117K	–	2739
2023 Q3	$117K	Buy	+15,270	New	+$117K	﹤0.01%	2457